News

Filter

Current filters:

DepomedWomen's Health

Depomed says BREEZE 3 data for Serada shows benefits for hot flashes

04-10-2012

USA-based Depomed (Nasdaq: DEPO) is presenting two abstracts from its Phase III clinical trial, BREEZE…

DepomedMetabolicsPharmaceuticalResearchSeradaWomen's Health

Depomed to file NDA for Serada; with Valeant sues Watson over Glumetza

20-04-2012

US drugmaker Depomed (Nasdaq: DEPO) says that it has completed a Type B pre-New Drug Application meeting…

DepomedDiabetesGenericsGlumetzaNorth AmericaPatentsPharmaceuticalRegulationResearchSeradaValeant PharmaceuticalsWatson PharmaceuticalsWomen's Health

Back to top